Welcome!
1H2021 results
Broker's Calls
Analysts mixed on Raffles Medical even as it appears immunised to the Covid-19 bug
The group’s PATMI of $39.4 million beat expectations of analysts from RHB and CGS-CIMB.
July 27, 2021
Results
Vicplas International reports 2.2 times earnings growth for 1HFY21
Revenue from its medical segment grew 36% on increased customer orders.
March 15, 2021
Broker's Calls
iX Biopharma remains a 'buy' from PhillipCapital despite $2.8 million net loss in 1H21
PhillipCapital is maintaining its “buy” call on iX Biopharma, but at a lower target price of 44.5 cents.
February 22, 2021
Results
Oxley reports 117% surge in 1H21 earnings of $34.1 mil on higher revenue, lower finance costs
Earnings per share (EPS) for the period stood at 0.81 cents compared to 0.37 cents the year before.
February 15, 2021
Results
Thomson Medical Group reports profit of $9.7 mil for 1H21 reversing from losses the year before
Excluding Covid-19 related grants, the group recorded a net profit after tax (NPAT) of $4.5 million.
February 08, 2021